Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Finished Goods (2019 - 2025)

Ptc Therapeutics has reported Finished Goods over the past 7 years, most recently at $21.7 million for Q4 2025.

  • Quarterly results put Finished Goods at $21.7 million for Q4 2025, up 156.75% from a year ago — trailing twelve months through Dec 2025 was $21.7 million (up 156.75% YoY), and the annual figure for FY2025 was $21.7 million, up 156.75%.
  • Finished Goods for Q4 2025 was $21.7 million at Ptc Therapeutics, up from $8.6 million in the prior quarter.
  • Over the last five years, Finished Goods for PTCT hit a ceiling of $21.7 million in Q4 2025 and a floor of $5.7 million in Q1 2022.
  • Median Finished Goods over the past 5 years was $7.0 million (2021), compared with a mean of $8.3 million.
  • Biggest five-year swings in Finished Goods: plummeted 38.3% in 2021 and later soared 156.75% in 2025.
  • Ptc Therapeutics' Finished Goods stood at $6.7 million in 2021, then decreased by 0.91% to $6.7 million in 2022, then surged by 74.79% to $11.6 million in 2023, then dropped by 27.45% to $8.4 million in 2024, then soared by 156.75% to $21.7 million in 2025.
  • The last three reported values for Finished Goods were $21.7 million (Q4 2025), $8.6 million (Q3 2025), and $7.5 million (Q2 2025) per Business Quant data.